Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 469.42Cr 71Cr 63Cr 58Cr 53Cr 98Cr 6.7TCr 100.25Cr 692.88Cr 278.14Cr 3.52TCr 264.69Cr 259.06Cr 11TCr P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 452.54Cr 68Cr 61Cr 56Cr 51Cr 95Cr 6.46TCr 97Cr 667.96Cr 268.14Cr 3.4TCr 255.17Cr 249.74Cr 11TCr EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day+1.00%
1 week-0.25%
Current month-15.59%
1 month-15.59%
3 months+6.04%
6 months-14.78%
Current year+1.64%
1 week 7.6
Extreme 7.6
8.41
1 month 7.58
Extreme 7.58
9.63
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.38
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
14.86
Manager TitleAgeSince
Chief Executive Officer 42 11/12/2017
Director of Finance/CFO 34 01/08/2019
Chief Operating Officer 45 25/08/2022
Director TitleAgeSince
Chairman 42 01/08/2019
Chairman 48 21/03/2019
Director/Board Member 46 21/03/2019
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Sell

Executive/Senior Manager

-2,000 0.0005%
14/09/21 Sell

Executive/Senior Manager

10,000 0.0025%
10/09/21 Sell

Executive/Senior Manager

77,000 0.0189%
Change 5-day change 1-year change 3-year change Capi.($)
+1.00%-0.25%-5.72%+12.40% 71Cr
+3.19%+11.31%+67.86%+150.58% 1,26300Cr
-0.73%+3.56%+44.51%+85.81% 66TCr
+1.41%+3.24%+29.22%+107.83% 52TCr
+0.42%+3.20%+54.15%+67.18% 39TCr
+2.18%+2.93%+73.30%+45.62% 37TCr
+1.12%+4.52%+35.30%+58.08% 31TCr
+6.96%+8.86%+11.27%+36.62% 29TCr
+1.15%+6.09%+59.59%+77.06% 25TCr
+3.06%+9.38%+44.11%+119.47% 21TCr
Average +1.66%+5.33%+41.36%+76.06% 42.63TCr
Weighted average by Cap. +1.19%+6.60%+50.87%+98.30%

Financials

2024 2025
Net sales 98Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.4TCr 21Cr 145.17Cr 58Cr 738.08Cr 55Cr 54Cr 2.33TCr 120.53Cr 18Cr 16Cr 15Cr 14Cr 25Cr 1.72TCr 26Cr 177.9Cr 71Cr 904.47Cr 68Cr 67Cr 2.85TCr
Net income 1.37Cr 20.51L 18.37L 16.9L 15.31L 28.62L 19Cr 29.15L 2.02Cr 80.89L 10Cr 76.98L 75.34L 32Cr 9.27Cr 1.39Cr 1.25Cr 1.15Cr 1.04Cr 1.94Cr 132.29Cr 1.98Cr 14Cr 5.49Cr 70Cr 5.23Cr 5.12Cr 219.46Cr
Net Debt 19Cr 2.84Cr 2.54Cr 2.34Cr 2.12Cr 3.96Cr 269.75Cr 4.04Cr 28Cr 11Cr 141.89Cr 11Cr 10Cr 447.48Cr -17Cr -2.54Cr -2.27Cr -2.09Cr -1.89Cr -3.54Cr -240.82Cr -3.61Cr -25Cr -10Cr -126.68Cr -9.52Cr -9.32Cr -399.5Cr
Projected Income Statement - Annual - Beijing Beilu Pharmaceutical Co., Ltd.
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
30/26/30 CN¥8.070 +1.00% 3,61,74,133
29/26/29 CN¥7.990 -0.99% 2,19,00,700
28/26/28 CN¥8.070 +6.04% 3,01,67,549
27/26/27 CN¥7.610 -5.47% 2,64,31,000
26/26/26 CN¥8.050 -0.49% 2,10,64,342

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Beijing Beilu Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 300016 Stock